Garrigues advises Vivebiotech on €3.5m capital increase

Garrigues advised San Sebastian-based biotechnology company Vivebiotech on a €3.5 million capital increase.

Vivebiotech is the only biotechnology company in Spain that produces lentiviral vectors for tests on rare diseases and hematological cancer.

The capital was raised from Easo Ventures, the Inveready venture capital fund, the Basque public company Dpri, Fundación Kutxa, and entrepreneurs from Euskadi.

The company will use the capital increase to multiply its production capacity by 30 per cent and increase its current workforce by 25 per cent.

A Garrigues team based in the firm’s San Sebastian office – including partner Carla Frangoni (pictured) and associate Gorka Esnal – advised on the deal.

Garrigues advises Vivebiotech on €3.5m capital increase

Juan fernandez

Iberian Lawyer, is a monthly digital magazine, published by LC Publishing, available in Spanish and English. It represents the main source of information in the legal business sector in Spain and Portugal. The digital magazine – and its portal – address to the protagonists of law firms and in-house lawyers. The magazine is available for free on the website and on Google Play and App Store.

In every issue of the magazine, you will find rankings of lawyers, special report on trends, interviews, information about deals and their advisors.

For further information, please visit the Group’s website

Iberian Legal Group, S.L.
Registered office: C/ Ríos Rosas 44A - 2 G,H 28003 Madrid España

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram